Information from the PrognoScan database indicated that higher expression of ALK is significantly correlated with lower patient survival in lung adenocarcinoma (Figure 5A), suggesting that if we could decrease ALK expression, patient survival rate might be improved. The gene discussed is ALK; the disease is lung adenocarcinoma.